Status:
UNKNOWN
Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study
Lead Sponsor:
Hasselt University
Collaborating Sponsors:
Ziekenhuis Oost-Limburg
Conditions:
COVID-19 Pneumonia
Lung Ultrasound
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
COVID-19 is a rapidly spreading and very contagious disease caused by a novel coronavirus that can lead to respiratory insufficiency. In many patients, the chest radiograph at first presentation be no...
Eligibility Criteria
Inclusion
- high probability CT thorax or chest X-ray for viral pneumonia within five days of the day of inclusion
- positive COVID-19 nasopharyngeal swab within 10 days of inclusion
- 18 years or older
- Oxygen saturation of \< 93% in ambient air
- Signed written informed consent
Exclusion
- Contra-indication for lung ultrasound
- Other causes of hypoxia or of pulmonary infiltrates on CT thorax or chest X-ray
Key Trial Info
Start Date :
April 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04338568
Start Date
April 16 2020
End Date
December 30 2020
Last Update
August 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziekenhuis Oost Limburg
Genk, Limburg, Belgium, 3600